Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980040/S174

TECNIS Odyssey IOL with TECNIS SIMPLICITY Delivery System (DRN00V); TECNIS Odyssey Toric II IOLs with TECNIS SIMPLICITY

Johnson & Johnson Surgical Vision, Inc. · Decision date Sep 11, 2025

FDA DECISIONP980040/S174

What did the FDA approve?

FDA records P980040/S174 as a supplement to PMA P980040, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Sep 11, 2025.

FDA approval order statement

approval for a change in the endotoxin specification limit for preloaded intraocular lens storage/delivery systems to harmonize this limit with the relevant intraocular device ISO Standard and FDA Guidance.
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Ophthalmic
Decision date
Sep 11, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P980040/S174
Regulatory pathway
PMA supplement
Product code
Not reported
Decision code
APPR
Decision date
Sep 11, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

Product code
Not reported

For the original device and its historical approval scope, see PMA P980040. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980040 · Original PMA

    SENSAR SOFT ACRYLIC UV-LIGHT ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS

  2. P980040/S174 received

    Application receipt date recorded by FDA.

  3. P980040/S175 · Related supplement

    TECNIS Odyssey Toric II IOL with TECNIS SIMPLICITY Delivery System, Model DRT

  4. P980040/S177 · Related supplement

    TECNIS Toric II 1-Piece IOLs, ZCU TECNIS Symfony Toric II Extended Range of Vision IOLs, ZXU TECNIS Eyhance Toric II IO

  5. P980040/S171 · Related supplement

    SENSAR Soft Acrylic Posterior Chamber IOL, SENSAR 1-piece IOL, TECNIS 1-Piece IOL, TECNIS Multifocal 1-Piece IOL, TECNIS

  6. P980040/S174 · FDA decision

    Real-Time Process

  7. P980040/S178 · Related supplement

    TECNIS Symfony Toric II OptiBlue Extended Range of Vision IOL with TECNIS Simplicity Delivery System, Models DXW150-375;

  8. P980040/S179 · Related supplement

    TECNIS SIMPLICITY Delivery System

  9. P980040/S181 · Related supplement

    SENSAR 1-piece IOL, AAB00; SENSAR Soft Acrylic Posterior Chamber IOL, Models AR40e, AR40E, and AR40M; TECNIS 1-Piece I

  10. P980040/S176 · Related supplement

    TECNIS PureSee IOL, Model DEN00V TECNIS PureSee Toric II IOLs, Model DET150, DET225, DET300, DET375

  11. P980040/S182 · Related supplement

    TECNIS Eyhance Toric II IOLs with SmartLOAD Delivery Technology (GIU150-600)

  12. P980040/S183 · Related supplement

    SENSAR 3-Piece Monofocal IOL, Models, AR40e, AR40E, AR40M, AR40MN

  13. P980040/S184 · Related supplement

    SENSARTM 1-Piece IOL, AAB00; TECNISTM 1-Piece IOL with TECNIS Simplicity Delivery System, DCB00; TECNISTM 1-Piece OptiB

  14. P980040/S186 · Related supplement

    SENSAR 3-Piece Monofocal IOL, SENSAR 1-piece IOL, TECNIS Multi-focal 1-pc, TECNIS 1-PC OptiBlue IOL, TECNIS OptiBlue 1-P

Timeline entries are records held by MedtechLedger for P980040. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980040

Product / regulatory recordCompanyPathwayDecision dateSource
Johnson & Johnson Surgical Vision, Inc.PMA approvalFeb 3, 2000FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementJul 22, 2025FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementSep 2, 2025FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementSep 10, 2025FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementOct 24, 2025FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementDec 16, 2025FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementJan 12, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementMar 11, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementMay 19, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementJun 3, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementJul 23, 2026FDA
Johnson & Johnson Surgical Vision, Inc.PMA supplementOct 19, 2026FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Johnson & Johnson Surgical Vision, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
31 Technology Dr., Suite 200, Irvine, CA, 92618

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records